Skip to main content

Loading market ticker...

Bal Pharma

Healthcare NSE:BALPHARMA

65.40INR
0.53 ( 0.82%)

Last update at April 2, 2026, midnight

Day Range

62.1666.99
LowHigh

52 Week Range

69.00 127.02
LowHigh

Fundamentals

  • Previous Close 64.87
  • Market Cap 1157.65M
  • Volume5,579
  • P/E Ratio 16.94
  • EBITDA 234.06M
  • Revenue TTM 2949.26M
  • Revenue Per Share TTM 185.44
  • Gross Profit TTM 1353.42M
  • Diluted EPS TTM 4.29

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 51.38M 90.47M 47.49M 91.83M 41.03M
Net income 72.15M 73.92M 25.72M 56.12M 47.42M
Total Revenue 3030.83M 3392.20M 3042.16M 2812.15M 2469.44M
Gross Profit 730.19M 770.20M 1254.63M 1114.81M 993.03M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 3356.90M 3195.26M 3131.72M 2605.33M 2400.80M
Intangible assets 119.98M 113.81M 104.57M 83.02M 72.48M
Other current assets 277.55M 267.84M 259.89M 4.43M 3.14M
Deferred long term liab - - 91.42M 77.83M 71.89M
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 37.35M 27.09M 3.74M 0.89M 1.65M
Operating Cash 42.32M 228.06M -18.44M 277.08M 217.81M
Free Cash Flow -145.55M 118.26M -164.89M 192.39M 183.68M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
BALPHARMA
Bal Pharma 		0.53 0.82% 65.40 1157.65 16.94
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-34.90 -2.02% 1693.60 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-50.00 -0.85% 5856.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-124.10 -3.02% 3987.20 1362716.66 63.48
CIPLA
Cipla Limited 		-3.50 -0.29% 1192.40 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.